T1	Participants 50 79	patients with chronic illness
T2	Participants 220 258	previously published randomized trial.
T3	Participants 1094 1149	HBI patients with chronic obstructive pulmonary disease
T4	Participants 467 547	home-based intervention (HBI) (n = 260) or to usual postdischarge care (n = 268)
